Loading...

Avadel Pharmaceuticals plc

AVDL•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$21.64
$0.00(0.00%)
U.S. Market opens in NaNh NaNm

Avadel Pharmaceuticals plc (AVDL) Stock Overview

Explore Avadel Pharmaceuticals plc’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap2.1B
P/E Ratio-7558.74
EPS (TTM)$-0.02
ROE-0.00%
Fundamental Analysis

AI Price Forecasts

1 Month$20.63
3 Months$32.43
1 Year Target$18.59

AVDL Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Avadel Pharmaceuticals plc (AVDL) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 62.19, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $18.59.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -7558.74 and a market capitalization of 2.1B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
1.03%
6-Month Change
42.46%
Year-to-Date (YTD) Change
0.56%
1-Year Change
144.80%
3-Year Change
135.73%
5-Year Change
114.90%
All-Time (Max) Change
84.17%

Contact Information

https://www.avadel.com
353 1 901 5201
10 Earlsfort Terrace, Dublin, NaN, 2

Company Facts

1,880 Employees
IPO DateJun 7, 1996
CountryIE

Frequently Asked Questions